Evidence of an association between cigarette smoking and latent tuberculosis infection (LTBI) is based on studies in special populations and/or from high prevalence settings. We sought to evaluate the association between LTBI and smoking in a low prevalence TB setting using population-based data from the National Health and Nutrition Examination Survey (NHANES).
In 1999–2000, NHANES assessed LTBI (defined as a tuberculin skin test measurement ≥10 mm) in participants, and those ≥20 years of age were queried regarding their tobacco use and serum cotinine was measured. We evaluated the association of LTBI with self-reported smoking history and smoking intensity in multivariable logistic regression models that adjusted for known confounders (gender, age, birthplace, race/ethnicity, poverty, education, history of BCG vaccination, and history of household exposure to tuberculosis disease).
Estimated LTBI prevalence was 5.3% among those ≥20 years of age. The LTBI prevalence among never smokers, current smokers, and former smokers was 4.1%, 6.6%, and 6.2%, respectively. In a multivariable model, current smoking was associated with LTBI (OR 1.8; 95% CI, 1.1–2.9). The association between smoking and LTBI was strongest for Mexican-American and black individuals. In multivariate analysis stratified by race/ethnicity, cigarette packs per day among Mexican-American smokers and cotinine levels among black smokers, were significantly associated with LTBI.
Citation: Horne DJ, Campo M, Ortiz JR, Oren E, Arentz M, Crothers K, et al. (2012) Association between Smoking and Latent Tuberculosis in the U.S. Population: An Analysis of the National Health and Nutrition Examination Survey. PLoS ONE 7(11): e49050. doi:10.1371/journal.pone.0049050
Editor: Adithya Cattamanchi, San Francisco General Hospital, University of California San Francisco, United States of America
Received: July 8, 2012; Accepted: October 3, 2012; Published: November 8, 2012
Copyright: © 2012 Horne et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health [K23 AI 85036-01 to DJH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
One-third of the world’s population is estimated to have latent tuberculosis infection (LTBI) and in 2010, 8.8 million people had tuberculosis disease (TB) . While it has been almost 2 decades since the World Health Organization (WHO) declared tuberculosis a global emergency , TB remains a leading cause of death worldwide . As a TB control strategy, WHO and other public health organizations recognize the importance of prevention of the most frequent TB risk factors . In 2007, several systematic reviews identified an association between smoking and TB, calling attention to the potential role of smoking in TB pathogenesis and its contribution to global disease burden –. For these reasons, WHO recommends tobacco cessation be part of TB control programs .
The relationship between tobacco and LTBI is less clear. LTBI is an asymptomatic state that is diagnosed by evaluation of the host immune response through tuberculin skin tests (TST) or interferon-gamma release assays . In addition to assessing the relationship with TB disease, the 2007 systematic reviews evaluated the evidence for an association between smoking and LTBI –. The included studies were limited to special populations, including prisoners, migrant workers, immigrants, and the homeless –, aside from one population-based study that was from a very high TB prevalence setting in South Africa . These studies were limited by potential misclassification of smoking behavior and variation in adjustment for potential confounders . Although meta-analysis of the studies showed an overall association between smoking and LTBI, the evidence was weaker than for TB disease . Furthermore, a recent study from South Africa found no association between smoking and LTBI .
There are no population-based studies from areas of low TB prevalence that evaluate the association between smoking and LTBI . Prior studies on associations between smoking and LTBI are not generalizable to low TB incidence countries –. In the US, a better understanding of associations between cigarette smoking and LTBI could improve the identification of at risk populations for LTBI screening.
The National Health and Nutrition Examination Survey (NHANES) is designed to assess the health and nutritional status of U.S. residents. NHANES 1999–2000 included an assessment of LTBI status, TB risk factors, smoking history, and serum cotinine levels , . We evaluated associations between self-reported smoking status and LTBI after adjusting for confounders. We also assessed associations between LTBI and intensity of smoking as defined by daily pack intensity, overall exposure history, and serum cotinine levels. Finally, we compared the results of self-reported smoking history to measured serum cotinine levels.
Materials and Methods
NHANES is a continuous program of studies conducted by the U.S. Centers for Disease Control and Prevention to assess the health and nutritional status of residents . NHANES subject selection is designed to obtain a representative sample of the U.S. civilian non-institutionalized population. NHANES 1999–2000 collected data on participant demographics, health history, tobacco history, and tuberculosis risk factors . We included participants 20 years of age and older as younger participants were administered a different tobacco history questionnaire.
NHANES offered participants skin tests with a tuberculin-purified protein derivative (PPD) product, PPD S-1 . Trained phlebotomists injected 0.1 ml of PPD intradermally using the Mantoux method and trained TST readers measured reactions 48–72 hours later. Participants with a history of a severe reaction to a prior TST were excluded. NHANES defined LTBI as an area of induration ≥10 mm in response to PPD regardless of participants’ TB risk factors , .
NHANES ascertained smoking history with the following question: “Have you smoked at least 100 cigarettes in your entire life?” Participants who responded affirmatively were considered ever smokers and were queried on current smoking status, “Do you now smoke cigarettes?” A response of “Every day” or “Some days” was coded as current smoker while a response of “Not at all” was coded as former smoker. Current and former smokers were asked about daily cigarettes smoked currently and at the time of quitting, respectively. We estimated packs per day as the self-reported number of cigarettes smoked per day divided by twenty and rounded to the nearest integer; and we assigned a value of one pack per day to those who smoke 1 to 20 cigarettes daily. We defined pack-years of cigarettes as the number of cigarettes per day smoked multiplied by years of smoking, divided by twenty, and rounded to the nearest integer.
We included known and potential risk factors for LTBI and TST reactivity in multivariable analyses: age, gender, race/ethnicity, poverty, education, exposure to household contacts with active tuberculosis, foreign birth, and prior bacillus Calmette-Guerin (BCG) vaccination , . In order to reduce the risk of disclosure, NHANES assigned adults ages 85 years and older an age of 85 years. NHANES defined race/ethnicity based on self-report and categorized respondents as white (non-Hispanic), black (non-Hispanic), Mexican-American, other Hispanic, and other; due to small number of participants in the latter two groups these were combined in our study . Poverty was defined as a poverty/income ratio < one; the poverty/income ratio is the family income over the prior 12 months divided by the poverty threshold and is adjusted for family size . Education was categorized as less than high school, high school graduate or equivalent, and education beyond high school. To evaluate a known history of tuberculosis exposure, subjects were asked “Have you ever lived in the same household with someone while that person was sick with tuberculosis or TB?” BCG vaccination leaves an identifiable scar in most individuals , and past BCG receipt was assessed through visual inspection by NHANES staff.
Cotinine is a major metabolite of nicotine that may be used as a marker for active smoking. Serum cotinine was measured by isotope dilution-high performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry; cotinine concentrations were derived from the ratio of native to labeled cotinine in the sample by comparisons to a standard curve . The laboratory limit for detection of cotinine was 0.05 ng/mL . We used cotinine levels to address two issues in these analyses. First, we used cotinine levels to estimate the accuracy of self-reported current smoking status using a cotinine level of 3 ng/mL to define active smoking . Second, we used cotinine levels to measure the intensity of cigarette exposure and model an association with LTBI.
For all questions, we coded a refusal to answer or response of “don’t know” as missing. Bivariate analyses were performed using the chi-square test for categorical variables or t-test for means when appropriate. All tests were two-sided and the level for determining statistical significance was set at p≤0.05. We accounted for the survey design by using the Taylor series linearization method to estimate variances and sampling errors . We calculated prevalence estimates using the NHANES Mobile Examination Center (1999–2000) 2- year weights and calculated additional weights based on TST nonparticipation to correct for bias in our regression analyses , . All of our pre-selected variables were included in the final multivariable models based on our initial hypotheses; subjects with missing data for variables of interest were excluded from regression analyses. There were low levels (<0.3%) of missing data among the variables that selected for inclusion in our models with the exception of poverty (13.3%). High levels of missing data were present for HIV status (49.7%); we did not include HIV status as a variable in the regression models due to the previously described absence of HIV-seropositive subjects with ≥5 mm of induration on TST testing in this NHANES survey . In this cross-sectional study, we used logistic regression models to analyze associations between LTBI and self-reported history of current and former smoking compared to life-long non-smokers in the entire sample and stratified by race/ethnicity. We also assessed associations between LTBI and smoking intensity as defined by self-reported packs per day, pack-years of smoking, and measured serum cotinine levels. Data analyses were performed using Stata 11 (StataCorp, College Station, TX).
We performed several sensitivity analyses. We restricted the multivariate analysis of smoking status and LTBI to participants whose serum cotinine levels were concordant with self-reported smoking status (i.e. current smokers with serum cotinine ≥3 ng/mL and never/former smokers with levels <3 ng/mL). Heavy alcohol use has been reported to affect the strength of the relationship between cigarette smoking and LTBI . Due to high proportions of missing data for alcohol use (19%), we evaluated the effect of heavy drinking (≥5 more drinks per day) in sensitivity analyses.
A total of 4880 participants in NHANES 1999–2000 were 20 years of age or older, of whom 3843 (78.8%) had TST results. LTBI was detected in 339 of the study participants (8.8% of those with TST results). In a weighted analysis, we estimated LTBI prevalence in the U.S. among individuals ≥20 years of age as 5.3% in 1999–2000. Estimates of LTBI prevalence among sub-groups are presented in Table 1. Current smokers had a significantly higher prevalence of LTBI compared to never smokers. Consistent with previously reported estimates, a higher prevalence of LTBI was observed among a number of subgroups including men, foreign-born, non-whites, the poor, less educated, BCG vaccinated, and those with a history of TB exposure .
Smoking Related Characteristics
A history of smoking as defined by more than 100 lifetime cigarettes was present in 49.7% of the population (95% confidence interval [CI], 46.2–53.3), of whom 49.3% (45.3–53.4) were former smokers and 50.6% (46.6–54.7) were current smokers. On average, smoking started at age 17.9 years (16.7–19.1) in all smokers and age 18.4 years (16.4–20.4) in foreign born smokers. Former smokers reported higher packs per day smoked at the time of quitting (1.29 packs per day, 1.24–1.35) and more pack-years (21.03, 19.1–22.9) than current smokers (1.23, 1.18–1.28, and 13.0, 11.3–14.7, respectively). Among never smokers and former smokers, cotinine levels averaged 8.2 ng/mL (5.5–10.9) and 22.8 ng/mL (11.0–34.5), respectively, compared to 196.6 ng/mL (186.9–206.4) in current smokers. Using serum cotinine levels to verify self-reported smoking status, serum cotinine levels were 3 ng/mL or higher in 96.2%, 11.8% and 5.2% of current, former, and never smokers, respectively. There were differences in smoking status by race/ethnicity (Table 2). Regardless of smoking status, black persons had higher serum cotinine levels compared to other races/ethnicities.
Smoking Status and LTBI Prevalence
In bivariate analyses, current smokers (odds ratio [OR] 1.65, 95% CI 1.11–2.46), but not former smokers (OR 1.55, 0.80–3.00), were at increased risk for LTBI. This finding was confirmed in a multivariable logistic regression model adjusting for known LTBI risk factors, where we observed a significant independent association between LTBI and current smoking (OR 1.72, 1.04–2.86), but not former smoking (OR 1.87, 0.90–3.91) (Table 3).
Smoking Status and LTBI Prevalence within Race/ethnicity Subgroups
We observed differences in the strength of the associations between smoking status (current and former smoking) and LTBI when using weighted versus unweighted (not presented) models. This suggests that associations between smoking status and LTBI differ by racial/ethnic subgroups that are over represented in the sample compared to population demographics. Therefore, we analyzed the association between LTBI and smoking status stratified by race/ethnicity in multivariable models that adjusted for age, gender, birth place, poverty/income ratio, history of TB exposure, history of BCG vaccination and education level (Table 4). Current smoking was significantly associated with LTBI among black persons (OR 1.90, 1.03–3.50) and Mexican-American (OR 2.12, 1.55–2.89) populations, but not among white or other populations. Among Mexican-American persons, former smoking was also associated with LTBI (OR 3.12, 1.33–7.31).
Intensity of Smoking Exposure and LTBI
We next evaluated the association between exposure to cigarettes and LTBI, modeling the degree of exposure to cigarettes in three different ways: self-reported packs per day, to reflect daily intensity presently or at the time of quitting, self-reported pack-years to measure intensity and duration of exposure, and serum cotinine levels, hypothesized to reflect a subject’s level of smoking intensity. Smoking status was not included in these models. In multivariate analyses of the entire cohort, neither packs per day nor pack-years were associated with LTBI (OR 1.30, 0.97–1. 67 and 1.00, 0.99–1.01, respectively). In analyses stratified by race/ethnicity, a significant association was observed among Mexican-Americans, OR 2.52 for each additional pack per day smoked (1.60–3.99), but not in other races/ethnicities. We did not find an association between total pack-years and LTBI among all subjects with a history of smoking, or when stratified by race/ethnicity.
Modeled as a continuous variable, cotinine levels were not independently associated with increased risk for LTBI in the sample as a whole. However, when analyzed by race/ethnicity, higher cotinine levels were associated with an increased risk of LTBI in black subjects: every 100 ng/mL increase in cotinine was associated with an OR of 1.28 for LTBI (1.06–1.55); this association was observed only among current black smokers.
When multivariable models were restricted to subjects whose self-reported smoking status was concordant with measured serum cotinine levels (2928 observations), we observed significant associations between LTBI and smoking status similar to those previously noted among all current smokers (OR 1.85, 1.04–3.29), black current smokers (OR 2.20, 1.01–4.79), and Mexican-American current (OR 2.48, 1.75–3.52) and former smokers (OR 3.03, 1.18–7.78).
We evaluated whether the inclusion of heavy alcohol use confounded the observed associations between smoking status and LTBI. In a multivariable model that contained all subjects with data on alcohol use (n = 2695), there was no association between LTBI and heavy alcohol use (OR 0.81, 95% CI 0.398–1.66). However, the inclusion of heavy alcohol use strengthened the associations of current and former smoking with LTBI (OR 2.47, 1.63–3.76, and 2.57, 1.21–5.49, respectively).
We evaluated associations between cigarette smoking and LTBI in a large representative sample of the U.S. population and found an independent association between current cigarette smoking and LTBI. While meta-analyses have found a significant relationship between smoking and LTBI –, the included studies were conducted in special populations at high risk for LTBI (i.e. homeless, incarcerated, and Vietnamese immigrants). Our population-based findings remained robust to sensitivity analyses that included serum cotinine verification of self-reported smoking status. Our findings suggest that in low TB prevalence countries cigarette smoking is a strong risk factor for LTBI.
In the analyses stratified by race/ethnicity, we observed a significant risk for LTBI in black and Mexican-American current smokers, in Mexican-American former smokers, and in Mexican-Americans and black persons by different measures of smoking intensity. There are several possible explanations for differences in the observed associations in risk of LTBI by race/ethnicity. There may be a true difference in how race/ethnicity affects the association between smoking and LTBI that could be due to innate or acquired characteristics. Differences by ethnicity have been observed in the metabolism of nicotine and other products of cigarettes, and levels of nicotine intake per cigarette in black individuals ; we found that compared by smoking status black participants had higher serum cotinine levels compared to other races/ethnicities. There is a lack of data on whether race/ethnicity modifies associations between LTBI and tobacco as all studies of associations between LTBI and cigarette smoking have included subjects from non-white backgrounds –, , , with the exception of one study from the United States in which 76% of participants were black , and one study conducted among Spanish participants that did not describe the race/ethnicity of participants . Alternatively, it is possible that cigarette smoking affects TST results differently by race/ethnicity. Finally, there may be unmeasured confounders, particularly related to socioeconomic status.
To our knowledge, only one study has shown a significant independent association between smoking exposure and LTBI . In this study of Vietnamese immigrants to Australia, duration of smoking in years was associated with LTBI (OR 1.04, 1.01–1.06). We used several metrics to assess smoking intensity in current and former smokers. Although we did not detect a difference in measures of smoking intensity and LTBI in the entire population, when we analyzed by race/ethnicity we found reported packs per day associated with LTBI in Mexican-American current and former smokers, and cotinine levels associated with LTBI in current black smokers. These findings support a dose-response relationship between smoking and LTBI. There is biological data to support a causal relationship between smoking and LTBI , . Alveolar macrophage may have a role key in determining whether an individual develops LTBI following exposure to M. tuberculosis . Macrophages from smokers may be less successful in controlling intracellular M. tuberculosis compared to never smokers .
There are limitations to our study. NHANES is a cross-sectional study and we were unable to determine if the initiation of cigarette smoking preceded the tuberculosis contact that led to LTBI. Among all study participants the mean age of smoking initiation was 17.9 years and in the foreign born 18.4 years. As the mean age of immigration in foreign-born participants was 37.7 years (35.0–40.4), it is likely that exposure to TB occurred while an individual was an active smoker. Second, our definition of LTBI was based on the TST which may produce both false positive and false negative results . However, we believe that the TST limitations were minimized by adjusting for a history of BCG vaccination, and our conforming to a definition for LTBI that has been previously used in NHANES 1999–2000 , . Third, misclassification of smoking status may have occurred; however, we verified self-reported status in current smokers with serum cotinine levels. Finally, there may be residual confounding.
In 2007, WHO published a monograph on integration of tobacco control into TB program activities . However, there are no recommendations regarding smoking and LTBI screening. Smoking status may identify individuals with higher prevalence of LTBI and increased risk for progression to active tuberculosis , . Associations between smoking, LTBI, and TB disease support consideration of LTBI screening in smokers from high-risk populations that would not be screened based on current guidelines. This screening could also provide an opportunity for smoking cessation interventions among active smokers, particularly among those diagnosed with LTBI .
In conclusion, the present study provides significant evidence of the independent relationship between cigarette smoking and LTBI. Our population-based study from the United States has important implications for other low TB prevalence settings in addressing TB control and elimination strategies.
Conceived and designed the experiments: DJH MC KC MN. Performed the experiments: DJH. Analyzed the data: DJH MC JRO KC MN. Wrote the paper: DJH MC JRO EO MA KC MN.
- 1. Tho DQ, Lan NT, Chau NV, Farrar J, Caws M (2011) Multiplex allele-specific polymerase chain reaction for detection of isoniazid resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 15: 799–803.
- 2. Pontino MV, Di Giulio B, Fernandez C, Imperiale B, Bodon A, et al. (2006) [Evaluation of a colorimetric micromethod for determining the minimal inhibitory concentration of antibiotics against Mycobacterium tuberculosis]. Rev Argent Microbiol 38: 145–151.
- 3. World Health Organization., International Union against Tuberculosis and Lung Disease. (2007) A WHO/the Union monograph on TB and tobacco control : joining efforts to control two related global epidemics. Geneva: World Health Organization. 96 p.
- 4. Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, et al. (2007) Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med 167: 335–342.
- 5. Lin HH, Ezzati M, Murray M (2007) Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLoS Med 4: e20.
- 6. Slama K, Chiang CY, Enarson DA, Hassmiller K, Fanning A, et al. (2007) Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis 11: 1049–1061.
- 7. Lonnroth K, Raviglione M (2008) Global epidemiology of tuberculosis: prospects for control. Semin Respir Crit Care Med 29: 481–491.
- 8. Horsburgh CR Jr, Rubin EJ (2011) Clinical practice. Latent tuberculosis infection in the United States. N Engl J Med 364: 1441–1448.
- 9. Anderson RH, Sy FS, Thompson S, Addy C (1997) Cigarette smoking and tuberculin skin test conversion among incarcerated adults. Am J Prev Med 13: 175–181.
- 10. Hussain H, Akhtar S, Nanan D (2003) Prevalence of and risk factors associated with Mycobacterium tuberculosis infection in prisoners, North West Frontier Province, Pakistan. Int J Epidemiol 32: 794–799.
- 11. McCurdy SA, Arretz DS, Bates RO (1997) Tuberculin reactivity among California Hispanic migrant farm workers. Am J Ind Med 32: 600–605.
- 12. Plant AJ, Watkins RE, Gushulak B, O'Rourke T, Jones W, et al. (2002) Predictors of tuberculin reactivity among prospective Vietnamese migrants: the effect of smoking. Epidemiol Infect 128: 37–45.
- 13. Solsona J, Cayla JA, Nadal J, Bedia M, Mata C, et al. (2001) Screening for tuberculosis upon admission to shelters and free-meal services. Eur J Epidemiol 17: 123–128.
- 14. den Boon S, van Lill SW, Borgdorff MW, Verver S, Bateman ED, et al. (2005) Association between smoking and tuberculosis infection: a population survey in a high tuberculosis incidence area. Thorax 60: 555–557.
- 15. van Zyl-Smit RN, Brunet L, Pai M, Yew WW (2010) The convergence of the global smoking, COPD, tuberculosis, HIV, and respiratory infection epidemics. Infect Dis Clin North Am 24: 693–703.
- 16. Brunet L, Pai M, Davids V, Ling D, Paradis G, et al. (2011) High prevalence of smoking among patients with suspected tuberculosis in South Africa. Eur Respir J 38: 139–146.
- 17. Bennett DE, Courval JM, Onorato I, Agerton T, Gibson JD, et al. (2008) Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999–2000. Am J Respir Crit Care Med 177: 348–355.
- 18. Khan K, Wang J, Hu W, Bierman A, Li Y, et al. (2008) Tuberculosis infection in the United States: national trends over three decades. Am J Respir Crit Care Med 177: 455–460.
- 19. Shiferaw G, Woldeamanuel Y, Gebeyehu M, Girmachew F, Demessie D, et al. (2007) Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 45: 1093–1097.
- 20. Mohammadzadeh A, Farnia P, Ghazvini K, Behdani M, Rashed T, et al. (2006) Rapid and low-cost colorimetric method using 2,3,5-triphenyltetrazolium chloride for detection of multidrug-resistant Mycobacterium tuberculosis. J Med Microbiol 55: 1657–1659.
- 21. Moore DA, Evans CA, Gilman RH, Caviedes L, Coronel J, et al. (2006) Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 355: 1539–1550.
- 22. Mengatto L, Chiani Y, Imaz MS (2006) Evaluation of rapid alternative methods for drug susceptibility testing in clinical isolates of Mycobacterium tuberculosis. Mem Inst Oswaldo Cruz 101: 535–542.
- 23. Jason J, Archibald LK, Nwanyanwu OC, Kazembe PN, Chatt JA, et al. (2002) Clinical and immune impact of Mycobacterium bovis BCG vaccination scarring. Infect Immun 70: 6188–6195.
- 24. Singh P, Wesley C, Jadaun GP, Malonia SK, Das R, et al. (2007) Comparative evaluation of Lowenstein-Jensen proportion method, BacT/ALERT 3D system, and enzymatic pyrazinamidase assay for pyrazinamide susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 45: 76–80.
- 25. Benowitz NL, Bernert JT, Caraballo RS, Holiday DB, Wang J (2009) Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am J Epidemiol 169: 236–248.
- 26. Brick JM, Kalton G (1996) Handling missing data in survey research. Stat Methods Med Res 5: 215–238.
- 27. Perez-Stable EJ, Herrera B, Jacob P 3rd, Benowitz NL (1998) Nicotine metabolism and intake in black and white smokers. JAMA 280: 152–156.
- 28. Shang S, Ordway D, Henao-Tamayo M, Bai X, Oberley-Deegan R, et al. (2011) Cigarette smoke increases susceptibility to tuberculosis–evidence from in vivo and in vitro models. J Infect Dis 203: 1240–1248.
- 29. Feng Y, Kong Y, Barnes PF, Huang FF, Klucar P, et al. (2011) Exposure to cigarette smoke inhibits the pulmonary T-cell response to influenza virus and Mycobacterium tuberculosis. Infect Immun 79: 229–237.
- 30. van Crevel R, Ottenhoff TH, van der Meer JW (2002) Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev 15: 294–309.
- 31. Oursler KK, Moore RD, Bishai WR, Harrington SM, Pope DS, et al. (2002) Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. Clin Infect Dis 34: 752–759.